athenahealth names new CTO

athenahealth has appointed Prakash Khot as chief technology officer (CTO), effective Jan. 25.

Khot will be responsible for leading all aspects of athenahealth’s technology vision and development. As CTO, his primary focus will be advancing the overall direction and development of athenahealth’s core technology platform, athenaNet. Software development, user experience design, technology infrastructure and data analytics will all fall under Khot’s purview.

“Sustaining athenaNet as an open platform is critical for enabling innovation in the health care cloud,” said Jonathan Bush, CEO of athenahealth. “The importance of our technology platform cannot be overstated for our business and health IT as a whole, and Prakash’s combination of technology expertise, leadership experience, and an entrepreneurial approach are exactly what we need to execute the roadmap that will make this possible.”

Chief Operating Officer Ed Park, who was athenahealth’s CTO from 2007 to 2010, will re-focus his energy on delivering and improving athenaNet’s existing services. Chief Product Officer Kyle Armbrester will remain focused on identifying and developing new services and products.

Khot has 24 years of technology industry experience, including delivering cloud-based big data, analytics, collaboration and IT management solutions, according to the company. 

Prior to joining athenahealth, he served as the chief technology and product officer of Kaseya, where he was responsible for the delivery of Kaseya’s cloud-based IT management platform. Khot also previously served as the senior vice president of engineering at salesforce.com where his role included management of the company’s big data and analytics platform and real-time collaboration efforts. He was the founding CTO of Dimdim and Automated Industrial Machinery, which were acquired by salesforce.com and Computer Associates, respectively.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup